El Hospital Universitario Valle de Hebrón​ es un centro sanitario de titularidad pública, administrado por el Servicio Catalán de Salud.

During the past decade, Hospital Univ Vall d'Hebron; Servicio de Oncologia conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 37 clinical trials were completed, i.e. on average, 75.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 20 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Univ Vall d'Hebron; Servicio de Oncologia" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "SOLTI Breast Cancer Research Group" with 2 trials as a collaborator and "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Univ Vall d'Hebron; Servicio de Oncologia" are "Breast Cancer" (11 trials), "Neoplasms" (6 trials), "Non-Small Cell Lung Cancer" (6 trials), "Colorectal Cancer" (5 trials) and "Solid Tumors" (5 trials). Many other conditions were trialed in "Hospital Univ Vall d'Hebron; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Univ Vall d'Hebron; Servicio de Oncologia" are "Drug" (70 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (22 trials), "Paclitaxel" (15 trials), "Placebo" (15 trials), "Bevacizumab" (11 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Univ Vall d'Hebron; Servicio de Oncologia" are 64 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Univ Vall d'Hebron; Servicio de Oncologia". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Hospital Univ Vall d'Hebron; Servicio de Oncologia, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Univ Vall d'Hebron; Servicio de Oncologia, 22 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".